PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study)

PHASE4RecruitingINTERVENTIONAL
Enrollment

2,000

Participants

Timeline

Start Date

September 15, 2022

Primary Completion Date

February 15, 2026

Study Completion Date

February 15, 2026

Conditions
Surgical Site Infection
Interventions
DRUG

povidone-iodine topical ointment

Intranasal povidone-iodine will be applied to the lower anterior nares (i.e. nostril) of patients undergoing HELEF orthopedic repair.

Trial Locations (6)

30303

NOT_YET_RECRUITING

Emory University, Atlanta

46202

RECRUITING

University of Indiana, Indianapolis

52242

RECRUITING

University of Iowa, Iowa City

63110

RECRUITING

Washington University, St Louis

75235

NOT_YET_RECRUITING

University of Texas Southwestern, Dallas

84108

RECRUITING

University of Utah, Salt Lake City

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Indiana University

OTHER

collaborator

University of Utah

OTHER

collaborator

Washington University School of Medicine

OTHER

collaborator

University of Texas

OTHER

collaborator

Emory University

OTHER

collaborator

PDI Healthcare

UNKNOWN

collaborator

Centers for Disease Control and Prevention

FED

lead

Loreen Herwaldt

OTHER

NCT05763602 - PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study) | Biotech Hunter | Biotech Hunter